Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Cash & Equivalents (2025)

Vsee Health (VSEE) has disclosed Cash & Equivalents for 3 consecutive years, with $291595.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Cash & Equivalents fell 73.63% year-over-year to $291595.0, compared with a TTM value of $291595.0 through Jun 2025, down 73.63%, and an annual FY2023 reading of $118734.0, changed N/A over the prior year.
  • Cash & Equivalents was $291595.0 for Q2 2025 at Vsee Health, down from $1.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.1 million in Q2 2024 and bottomed at $507.0 in Q3 2023.
  • Average Cash & Equivalents over 3 years is $260666.5, with a median of $74797.5 recorded in 2023.
  • The sharpest move saw Cash & Equivalents surged 3483.72% in 2024, then plummeted 73.63% in 2025.
  • Year by year, Cash & Equivalents stood at $118734.0 in 2023, then soared by 831.47% to $1.1 million in 2024, then tumbled by 73.63% to $291595.0 in 2025.
  • Business Quant data shows Cash & Equivalents for VSEE at $291595.0 in Q2 2025, $1.1 million in Q2 2024, and $118734.0 in Q4 2023.